Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

v3.24.1.1.u2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenues, net $ 3,634 $ 19,303
Cost of revenues 4,067 8,783
Gross (loss) profit (433) 10,520
Operating expenses:    
Diagnostic expenses 0 1,203
General and administration 7,593 8,298
Research and development 272 144
Total operating expenses 7,865 9,645
(Loss) Income from operations (8,298) 875
Interest income, net 0 11
Interest expense (515) (215)
Other expense (18) (107)
(Loss) Income from operations before income taxes (8,831) 564
Income tax benefit (expense) 2,566 (14)
(Loss) income from operations after income taxes (6,265) 550
Net (loss) income (6,265) 550
Other comprehensive income (loss):    
Unrealized gain (loss) on marketable debt securities 160 (665)
Total comprehensive loss $ (6,105) $ (115)
Earnings (loss) per share:    
Earnings per share, basic (in dollars per share) $ (0.35) $ 0.03
Earnings per share, diluted (in dollars per share) $ (0.35) $ 0.03
Weighted average common shares outstanding:    
Weighted average common shares outstanding, basic (in shares) 18,045 16,748
Weighted average common shares outstanding, diluted (in shares) 18,045 18,061